Elite Pharma Inc (ELTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ELTP | ZVRA | ACRV | ||
| Company | Elite Pharma Inc | Zevra Therapeutics Inc | Acrivon Therapeutics Inc | ||
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | ||
| Open | 0.2970 | 7.43 | 10.16 | ||
| High | 0.2980 | 7.70 | 10.16 | ||
| Low | 0.2520 | 7.29 | 8.92 | ||
| Last | 0.2767 | 7.65 | 9.49 | ||
| Change | -0.0023 | +0.26 | -0.49 | ||
| % Change | -0.82% | +3.52% | -4.91% | ||
| Volume | 3,566,400 | 436,100 | 75,900 | ||
| 20-Day Average Volume | 1,836,290 | 1,245,450 | 62,415 | ||
| Previous Close | 0.2790 | 7.39 | 9.98 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | No | Yes | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2080 | 7.26 | 8.26 | ||
| 20-Day Raw Stochastic | 79.29% | 59.28% | 79.64% | ||
| 20-Day Relative Strength | 77.04% | 60.83% | 60.12% | ||
| Weighted Alpha | +122.27 | +26.45 | -30.86 | ||
| Today's Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Last Month's Opinion | 64% Buy | 40% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +38.28% since 08/23/24 | +6.55% since 08/23/24 | +1.39% since 08/23/24 | ||
| Low | 0.2050 on 08/26/24 | 7.00 on 08/27/24 | 8.92 on 08/30/24 | ||
| High | 0.3065 on 08/29/24 | 7.70 on 08/30/24 | 10.16 on 08/30/24 | ||
| 1-Month | |||||
| %Chg | +48.29% since 07/30/24 | +39.09% since 07/30/24 | +15.17% since 07/30/24 | ||
| Low | 0.1626 on 08/05/24 | 5.95 on 07/31/24 | 6.87 on 08/08/24 | ||
| High | 0.3065 on 08/29/24 | 8.44 on 08/05/24 | 10.16 on 08/30/24 | ||
| 3-Month | |||||
| %Chg | +53.72% since 05/30/24 | +63.81% since 05/30/24 | +25.36% since 05/30/24 | ||
| Low | 0.1620 on 06/10/24 | 4.20 on 07/05/24 | 5.50 on 06/28/24 | ||
| High | 0.3065 on 08/29/24 | 8.44 on 08/05/24 | 10.16 on 08/30/24 | ||
| 6-Month | |||||
| %Chg | +67.80% since 02/29/24 | +13.50% since 02/29/24 | +95.27% since 02/29/24 | ||
| Low | 0.1213 on 04/23/24 | 4.20 on 07/05/24 | 4.49 on 03/11/24 | ||
| High | 0.3065 on 08/29/24 | 8.44 on 08/05/24 | 11.90 on 04/09/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 295,591 | 320,175 | 293,023 | ||
| Shares Outstanding, K | 1,068,273 | 41,853 | 30,877 | ||
| Annual Sales | 56,630,000 | 27,460,000 | 0 | ||
| Annual Net Income | 20,110,000 | -46,050,000 | -60,390,000 | ||
| Last Quarter Sales | 18,800,000 | 4,450,000 | 0 | ||
| Last Quarter Net Income | 620,000 | -19,930,000 | -18,800,000 | ||
| 60-Month Beta | 0.11 | 1.97 | 0.79 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 08/14/24 | -0.48 on 08/13/24 | -0.52 on 08/13/24 | ||
| Latest Earnings Date | 08/14/24 | 08/13/24 | 08/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 27.90 | 0.00 | 0.00 | ||